Protagenic Therapeutics, Inc. (PTIX) — 分析师展望 / 分析师共识目标价为. 基于 1 位分析师评级, 共识为 看涨 — 1 买入.
分析师预估 每股收益(EPS)为 $-34.16 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.13 vs 预期 $-34.16 (超预期 +96.7%). 2025: 实际 $-3.45 vs 预期 $-35.28 (超预期 +90.2%). 分析师准确度: 0%.
PTIX 分析师评级
Buy
基于过去3个月内 1 位分析师对 Protagenic Therapeutics, Inc. 的评级
EPS 预测 — PTIX
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.13
vs Est –$34.16
▲ 2,923.0% off
2025
Actual –$3.45
vs Est –$35.28
▲ 922.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — PTIX
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.